Assenagon Asset Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.8M Buy
303,433
+208,305
+219% +$11.8M 0.03% 396
2026
Q1
$6.11M Sell
95,128
-110,767
-54% -$10.1M 0.01% 550
2025
Q4
$26.8M Buy
205,895
+191,780
+1,359% +$26.3M 0.04% 315
2025
Q3
$1.52M Sell
14,115
-33,523
-70% -$3.65M ﹤0.01% 860
2025
Q2
$4.4M Sell
47,638
-58,481
-55% -$4.59M 0.01% 598
2025
Q1
$9.4M Sell
106,119
-161,495
-60% -$14M 0.02% 426
2024
Q4
$20.6M Sell
267,614
-61,642
-19% -$4.31M 0.03% 351
2024
Q3
$14M Sell
329,256
-37,040
-10% -$1.25M 0.03% 441
2024
Q2
$9.57M Buy
+366,296
New +$6.94M 0.02% 440

Other funds holding WGS

Assenagon Asset Management's WGS Position: Q2 2026 in Review

Assenagon Asset Management increased its GeneDx Holdings (WGS) stake by 219% in Q2 2026, buying an estimated $11.8M and bringing the position to 303,433 shares worth $20.8M. The position accounts for 0.03% of the portfolio, ranked #396.

Assenagon Asset Management first reported a position in WGS in Q2 2024 and has held it in 9 quarters since. The position peaked at $26.8M in Q4 2025. 15 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Assenagon Asset Management held 303,433 shares of GeneDx Holdings worth $20.8M as of Q2 2026.
  • Assenagon Asset Management bought 208,305 GeneDx Holdings shares in Q2 2026, an estimated $11.8M.
  • GeneDx Holdings made up 0.03% of Assenagon Asset Management's portfolio in Q2 2026, its #396 holding.
  • Assenagon Asset Management first reported a position in GeneDx Holdings in Q2 2024 and has held it in 9 quarters since.
  • Assenagon Asset Management's GeneDx Holdings position peaked at $26.8M in Q4 2025.
  • 15 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.